Aurora offers the Aurora‑RT™ system, which integrates a 6 MV linear accelerator with real‑time MR imaging to deliver adaptive radiotherapy. The platform provides high‑quality MR scans for precise patient alignment before treatment and continuous MR guidance during beam delivery, enabling accurate tumor tracking and reduced electron return effect.
Funding
Funding not disclosed
Founders
Product
Problem
Conventional radiotherapy systems rely on cone‑beam CT for image guidance, which provides limited soft‑tissue contrast and cannot be acquired concurrently with beam delivery. This limits the precision of tumor targeting, forces larger treatment margins, and can increase radiation exposure to healthy tissue.
Solution
Aurora‑RT™ integrates a 6 MV linear accelerator with real‑time magnetic resonance imaging, delivering adaptive radiotherapy with continuous MR guidance during beam delivery. High‑quality MR scans are obtained before treatment for exact patient alignment, and the concurrent MR imaging enables real‑time tumor tracking and gating, minimizing the electron return effect. By reducing reliance on low‑contrast CT images and allowing on‑the‑fly adaptation, the system aims to shrink treatment margins, improve dose conformity, and lower side‑effects for cancer patients.
Target Audience
Primary customers are radiation oncology departments and cancer treatment centers seeking advanced image‑guided radiotherapy solutions to improve treatment accuracy and reduce toxicity.
Features
- 6 MV linear accelerator combined with a concurrent MR imaging suite for simultaneous radiation delivery and soft‑tissue visualization
- High‑resolution MR scans for precise patient positioning prior to each treatment session
- Real‑time MR‑guided tumor tracking and gating during beam delivery to maintain alignment throughout the dose
- Design that minimizes electron return effect, enhancing patient comfort and safety
- FDA, CE, and UKCA approved platform ready for clinical deployment in major markets